Frontline Combination of Hyper-CVAD with Ponatinib for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia-6-Year Follow-up Results

被引：1

作者：

Nasnas, Patrice ^{[1
]}

Jabbour, Elias ^{[1
]}

Short, Nicholas ^{[1
]}

Sasaki, Koji ^{[1
]}

Ravandi, Farhad ^{[1
]}

Jain, Nitin ^{[2
]}

Daver, Naval ^{[1
]}

Pemmaraju, Naveen ^{[1
]}

Yilmaz, Musa ^{[2
]}

Kadia, Tapan M. ^{[2
]}

Garris, Rebecca ^{[1
]}

Garcia-Manero, Guillermo ^{[1
]}

DiNardo, Courtney D. ^{[1
]}

Konopleva, Marina ^{[3
]}

Wierda, William G. ^{[4
]}

Kwari, Monica ^{[1
]}

Loiselle, Christopher ^{[1
]}

Milton, Anna ^{[1
]}

Rivera, Juan ^{[1
]}

Banks, Glenda ^{[1
]}

Kantarjian, Hagop ^{[5
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[3] MD Anderson Canc Ctr, Houston, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Div Canc Med, Houston, TX 77030 USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-167761

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3250 / 3252

页数：3

共 50 条

[1] Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results
Kantarjian, Hagop
Short, Nicholas J.
Jain, Nitin
Sasaki, Koji
Huang, Xuelin
Haddad, Fadi G.
Khouri, Issa
DiNardo, Courtney D.
Pemmaraju, Naveen
Wierda, William
Garcia-Manero, Guillermo
Kebriaei, Partow
Garris, Rebecca
Loghavi, Sanam
Jorgensen, Jeffrey
Kwari, Monica
O'Brien, Susan
Ravandi, Farhad
Jabbour, Elias
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (03) : 493 - 501
[2] Phase II Study of the Frontline Hyper-CVAD in Combination with Ponatinib for Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Sasaki, Koji
Jabbour, Elias J.
Ravandi, Farhad
Daver, Naval G.
Pemmaraju, Naveen
Thomas, Deborah A.
Khouri, Rita B.
Yilmaz, Musa
Kadia, Tapan M.
Short, Nicholas J.
Garris, Rebecca
Garcia-Manero, Guillermo
DiNardo, Courtney D.
Konopleva, Marina
Estrov, Zeev
Jain, Nitin
Wierda, William G.
Jeanis, Twilla Victoria
Cortes, Jorge E.
O'Brien, Susan M.
Kantarjian, Hagop M.
BLOOD, 2016, 128 (22)
[3] Hyper-CVAD Plus Ponatinib Versus Hyper-CVAD Plus Dasatinib as Frontline Therapy for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Propensity Score Analysis
Sasaki, Koji
Jabbour, Elias J.
Ravandi, Farhad
Short, Nicholas J.
Thomas, Deborah A.
Garcia-Manero, Guillermo
Daver, Naval G.
Kadia, Tapan M.
Konopleva, Marina Y.
Jain, Nitin
Issa, Ghayas C.
Jeanis, Vicki
Moore, Haim G.
Garris, Rebecca S.
Pemmaraju, Naveen
Cortes, Jorge E.
O'Brien, Susan M.
Kantarjian, Hagop M.
CANCER, 2016, 122 (23) : 3650 - 3656
[4] Frontline Hyper-CVAD with Ponatinib for Patients (pts) with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: Results of a Phase II Study
Sasaki, Koji
O'Brien, Susan
Ravandi, Farhad
Thomas, Deborah A.
Moore, Haim G.
Cortes, Jorge E.
Pemmaraju, Naveen
Yilmaz, Musa
Kadia, Tapan
Garris, Rebecca
Garcia-Manero, Guillermo
Jeanis, Twilla Victoria
Chahoud, Jad
Borthakur, Gautam
Wierda, William
Ferrajoli, Alessandra
Kantarjian, Hagop M.
Jabbour, Elias
BLOOD, 2015, 126 (23)
[5] UPDATED RESULTS OF A PHASE II STUDY OF HYPER-CVAD PLUS PONATINIB AS FRONTLINE THERAPY FOR ADULTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Short, N.
Kantarjian, H.
Ravandi, F.
Daver, N.
Pemmaraju, N.
Thomas, D.
Yilmaz, M.
Kadia, T.
Sasaki, K.
Garris, R.
Garcia-Manero, G.
DiNardo, C.
Konopleva, M.
Estrov, Z.
Jain, N.
Wierda, W.
Jeanis, V.
Cortes, J.
O'Brien, S.
Jabbour, E.
HAEMATOLOGICA, 2017, 102 : 198 - 198
[6] Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib
Yuya Sasaki
Hagop M. Kantarjian
Nicholas J. Short
Feng Wang
Ken Furudate
Hidetaka Uryu
Rebecca Garris
Nitin Jain
Koji Sasaki
Farhad Ravandi
Marina Konopleva
Guillermo Garcia-Manero
Latasha Little
Curtis Gumbs
Li Zhao
P. Andrew Futreal
Koichi Takahashi
Elias Jabbour
Leukemia, 2022, 36 : 1253 - 1260
[7] Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib
Sasaki, Yuya
Kantarjian, Hagop M.
Short, Nicholas J.
Wang, Feng
Furudate, Ken
Uryu, Hidetaka
Garris, Rebecca
Jain, Nitin
Sasaki, Koji
Ravandi, Farhad
Konopleva, Marina
Garcia-Manero, Guillermo
Little, Latasha
Gumbs, Curtis
Zhao, Li
Futreal, P. Andrew
Takahashi, Koichi
Jabbour, Elias
LEUKEMIA, 2022, 36 (05) : 1253 - 1260
[8] A Comprehensive Cancer Center Experience with Hyper-CVAD Plus Ponatinib As Frontline Therapy for Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Othman, Tamer
Moskoff, Benjamin
Tenold, Matthew
Azenkot, Tali
Krackeler, Margaret
Fisch, Samantha C.
Potter, Laura A.
Kaesberg, Paul R.
Welborn, Jeanna
Wun, Ted
Esteghamat, Naseem
Hoeg, Rasmus T.
Rosenberg, Aaron S.
Abedi, Mehrdad
Tuscano, Joseph
Jonas, Brian A.
BLOOD, 2021, 138
[9] Prognostic Significance of Genetic Alterations in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD Plus Dasatinib or Hyper-CVAD Plus Ponatinib
Sasaki, Yuya
Kantarjian, Hagop M.
Short, Nicholas J.
Jain, Nitin
Sasaki, Koji
Ravandi, Farhad
Konopleva, Marina
Garcia-Manero, Guillermo
Little, Latasha
Gumbs, Curtis
Zhao, Li
Futreal, P. Andrew
Wang, Feng
Furudate, Ken
Garris, Rebecca
Takahashi, Koichi
Jabbour, Elias
BLOOD, 2020, 136
[10] Frontline hyper-CVAD plus ponatinib for patients with Philadelphia chromosome positive acute lymphoblastic leukemia: Updated results of a phase II study.
Short, Nicholas James
Kantarjian, Hagop M.
Ravandi, Farhad
Daver, Naval Guastad
Pemmaraju, Naveen
Thomas, Deborah A.
Yilmaz, Musa
Kadia, Tapan M.
Sasaki, Koji
Garris, Rebecca
Garcia-Manero, Guillermo
Dinardo, Courtney Denton
Konopleva, Marina
Estrov, Zeev
Jain, Nitin
Wierda, William G.
Jeanis, Vicky
Cortes, Jorge E.
O'Brien, Susan Mary
Jabbour, Elias
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

← 1 2 3 4 5 →